Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (131-140 of 542) with videos related to

Pageof 55
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1993
Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399M A Pfaller, A L Barry, P C Fuchs
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Dirithromycin disc susceptibility tests: interpretative criteria and quality control parametersA L Barry, M A Pfaller, P C Fuchs
Journal of Clinical Microbiology|July 1, 1996
Strain variation among and antifungal susceptibilities of isolates of Candida kruseiY F Berrouane, R J Hollis, M A Pfaller
Pharmacotherapy|June 10, 1998
Update on clinical antifungal susceptibility testing for Candida speciesR E Lewis, M E Klepser, M A Pfaller
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1991
Failure to isolate methicillin-resistant Staphylococcus aureus from stethoscopes in two hospitals with endemic strainsA F Widmer, M A Pfaller, R P Wenzel
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individualsE Blignaut, S Messer, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1988
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019M A Pfaller, T Gerarden, M Yu, et al.
Journal of Clinical Microbiology|February 1, 1994
Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicansM A Pfaller, C Grant, V Morthland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996
The positive predictive value of isolating coagulase-negative staphylococci from blood culturesL A Herwaldt, M Geiss, C Kao, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1994
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrataM A Pfaller, M J Bale, B Buschelman, et al.
Pageof 55

Showing results (131-140 of 542) with videos related to

Sort By:
Pageof 55
Antimicrobial Agents and Chemotherapy|April 1, 1993
Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399M A Pfaller, A L Barry, P C Fuchs
The Journal of Antimicrobial Chemotherapy|March 1, 1993
Dirithromycin disc susceptibility tests: interpretative criteria and quality control parametersA L Barry, M A Pfaller, P C Fuchs
Journal of Clinical Microbiology|July 1, 1996
Strain variation among and antifungal susceptibilities of isolates of Candida kruseiY F Berrouane, R J Hollis, M A Pfaller
Pharmacotherapy|June 10, 1998
Update on clinical antifungal susceptibility testing for Candida speciesR E Lewis, M E Klepser, M A Pfaller
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1991
Failure to isolate methicillin-resistant Staphylococcus aureus from stethoscopes in two hospitals with endemic strainsA F Widmer, M A Pfaller, R P Wenzel
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individualsE Blignaut, S Messer, R J Hollis, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1988
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019M A Pfaller, T Gerarden, M Yu, et al.
Journal of Clinical Microbiology|February 1, 1994
Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicansM A Pfaller, C Grant, V Morthland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996
The positive predictive value of isolating coagulase-negative staphylococci from blood culturesL A Herwaldt, M Geiss, C Kao, et al.
Diagnostic Microbiology and Infectious Disease|June 1, 1994
Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrataM A Pfaller, M J Bale, B Buschelman, et al.
Pageof 55